Embed presentation
Download to read offline













Tempo reported strong financial results in 2Q08, with net revenue increasing 27% to R$169 million and EBITDA growing 87% to R$18.9 million. The health segment saw revenue growth of 37% and a 15.5% EBITDA margin. The dental segment, including recent acquisitions, grew revenue 202% with a 24.7% EBITDA margin. The assistance segment grew revenue 13% with an 11.7% EBITDA margin. Tempo continues to grow organically and through acquisitions while maintaining asset-light operations.











